Wireless or leadless pacemakers, commonly implanted in adults, may be a safe and effective short-term option for children with slow heartbeats, according to new research published today in Circulation ...

Just a few weeks after Abbott presented the successful results of a trial of its Aveir DR dual-chamber leadless pacemaker system—data that it said had been promptly submitted for regulatory review—the ...

Please provide your email address to receive an email when new articles are posted on . The world’s first dual-chamber leadless pacing system has been approved by ...

A new leadless dual-chamber pacemaker for patients with heart issues could be available later this year, according to new research published last week and funded by Abbott Medical. The U.S. Food and ...

Patients who require a new permanent pacemaker after TAVI do just as well with leadless devices out to 2 years as they do with transvenous pacemakers, according to an analysis of real-world data from ...

Patients who received leadless pacemakers experienced fewer short-term and mid-term complications overall than those who had traditional transvenous pacemakers, a Cleveland Clinic-led research study ...

MANCHESTER, UK — There have been many recent advances in cardiac rhythm management, notably the use of leadless pacemakers and subcutaneous implantable cardioverter defibrillators (S-ICDs), experts ...

Every year more than one million people receive a pacemaker. Until now, leadless versions were only available for 20% of these patients. However, thanks to an international consortium led by Amsterdam ...

ABBOTT PARK, Ill., Nov. 12, 2021 /PRNewswire/ -- Abbott (NYSE: ABT) today announced new, late-breaking data from the global Leadless II IDE study evaluating Abbott's investigational Aveir leadless ...

Please provide your email address to receive an email when new articles are posted on . The world’s first dual-chamber leadless pacing system was named a top invention of 2023. The first implantation ...

Leadless pacemaker technology represents a significant advancement in cardiac rhythm management, eliminating the need for transvenous leads and reducing many of the complications associated with ...